Nursing and Health Professions
Palliative Therapy
96%
Interstitial Lung Disease
80%
Diseases
79%
Dyspnea
73%
Patient
60%
Hospital
35%
Symptom
35%
Medical Specialist
32%
Inpatient
26%
Quality of Life
26%
Caregiver
24%
Systematic Review
22%
Synthesis
17%
Opiate
17%
Cost Effectiveness Analysis
16%
Health Status
15%
Clinician
15%
Patient-Reported Outcome
15%
Health Practitioner
14%
Adult
14%
Control
14%
Analysis
12%
Numeric Rating Scale
11%
Family
11%
Death
11%
Consultation
10%
Obstructive Lung Disease
10%
Distress Syndrome
10%
Forced Vital Capacity
10%
Confidence Interval
9%
Lung Disease
9%
Primary Medical Care
8%
Meta Analysis
8%
Fibrosing Alveolitis
8%
Mirtazapine
7%
Consensus
7%
Clinical Practice
7%
Psychometry
7%
Malignant Neoplasm
7%
Deterioration
6%
Depression
6%
Physician
6%
Base
6%
Prevalence
6%
Minimal Clinically Important Difference
6%
Rasch Analysis
6%
Hospital Admission
6%
Health Care Delivery
6%
Drug Screening
6%
Cohort Analysis
6%
Medicine and Dentistry
Patient
100%
Symptomatic Treatment
83%
Interstitial Lung Disease
73%
Symptom
42%
Disease
41%
Dyspnea
39%
Quality of Life
29%
Health
27%
Hospital
24%
Silo-Filler's Disease
15%
Patient-Reported Outcome
15%
Person
14%
Idiopathic Pulmonary Fibrosis
14%
Caregiver
14%
Systematic Review
14%
Observational Study
13%
COVID-19
13%
Inpatient
12%
Death
11%
Forced Vital Capacity
10%
Symptom Management
9%
Health Status
9%
Cost-Effectiveness Analysis
9%
Experience
9%
Chronic Obstructive Pulmonary Disease
8%
Randomized Controlled Trial
8%
Consultation
8%
Coughing
8%
Obstetric Delivery
8%
Amaurosis
7%
Randomized Clinical Trial
6%
Progressive Disease
6%
Retrospective Study
6%
Prevalence
6%
Ethnic Minority Group
6%
Rasch Analysis
6%
Patient Experience
6%
Respiratory Disease
6%
Drug Screening
6%
Numeric Rating Scale
6%
Older People
6%
General Practitioner
6%
Adaptation
6%
Therapeutic Procedure
6%
Diagnosis
5%
Pulmonary Rehabilitation
5%
Assessment
5%
Analysis
5%
Deterioration
5%
